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Field strengthGas calibrated fMRI in its most common form uses hypercapnia in conjunction with the Davis model to quantify
relative changes in the cerebral rate of oxygen consumption (CMRO2) in response to a functional stimulus. It is
most commonly carried out at 3 T but, as 7 T research scanners are becomingmore widespread and themajority
of clinical scanners are still 1.5 T systems, it is important to investigate whether themodel used remains accurate
across this range of ﬁeld strengths. Ten subjects were scanned at 1.5, 3 and 7 T whilst performing a bilateral
ﬁnger-tapping task as part of a calibrated fMRI protocol, and the results were compared to a detailed signal
model. Simulations predicted an increase in value and variation in the calibration parameter M with ﬁeld
strength. Two methods of deﬁning experimental regions of interest (ROIs) were investigated, based on
(a) BOLD signal and (b) BOLD responses within grey matter only. M values from the latter ROI were in closer
agreement with theoretical predictions; however, reassuringly, ROI choice had less impact on CMRO2 than on
M estimates. Relative changes in CMRO2 during motor tasks at 3 and 7 T were in good agreement but were
over-estimated at 1.5 T as a result of the lower signal to noise ratio. This result is encouraging for future studies
at 7 T, but also highlights the impact of imaging and analysis choices (such asASL sequence and ROI deﬁnition) on
the calibration parameter M and on the calculation of CMRO2.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Gas calibrated functional magnetic resonance imaging (fMRI) has
emerged as a promising tool to non-invasively measure stimulus
evoked changes in the cerebral metabolic rate of oxygen consumption
(CMRO2) (Davis et al., 1998; Hoge, 2012). Not only is this more directly
physiologically relevant than measuring only the blood oxygen level-
dependent (BOLD) signal, but it has also been shown to bemore consis-
tent between subjects and between scanning sessions (Krieger et al.,
2014).
Calibrated fMRI is most commonly performed at 3 T, but with the
emergence of 7 T research systems there is interest in translating the
method to higher ﬁeld strengths. It is clear that as a physiological pa-
rameter CMRO2 should not be affected by the ﬁeld strength at which
it is measured. However, calibrated fMRI relies on a simple model of
the BOLD signal known as the Davis model (Davis et al., 1998) and it
is unclear how translation to different ﬁeld strengths affects its accura-
cy. Due to the continuing clinical dominance of 1.5 T scanners, we were
also interested in revisiting the use of this lower ﬁeld strength, enabling
a three-way comparison to be performed. Simulations of the calibrated
fMRI experiment suggest that the method is feasible at these ﬁelde Hospital, Oxford OX3 9DU.
. This is an open access article understrengths, so long as the Davis model parameters are adjusted to reﬂect
the altered BOLD sensitivity (Blockley et al., 2013; Griffeth et al., 2013).
It has also been predicted that systematic error may be increased at 7 T
compared with lower ﬁeld strengths (Griffeth et al., 2013). Experimen-
tal conﬁrmation of these ﬁndings has so far not been performed.
The aim of this study was to carry out a direct comparison of the hy-
percapnia calibrated fMRI method at 1.5, 3 and 7 T, in order to test the
level of agreement in the measured estimates of relative CMRO2 across
ﬁeld strengths. Detailed simulations of the BOLD signal were performed
to predict general trends in the calibration parameter M across ﬁeld
strengths, and to provide a basis for interpreting the experimental re-
sults. Implicitly this study is also an investigation into the robustness
of the Davis model itself, which was originally developed for use at
1.5 T, and how well it translates across ﬁeld strengths.
Theory
TheDavismodel (Eq. (1)) describes the extravascular BOLD signal as
a function of changes in cerebral blood ﬂow (CBF) and CMRO2 (Davis
et al., 1998; Hoge et al., 1999). Subscript 0 variables represent baseline
values. Changes in CBF are related to changes in cerebral blood volume
(CBV) via the Grubb exponentα (Grubb et al., 1974). This physiological
interpretation of α was retained and was therefore set independent of
ﬁeld strength as 0.2 (Chen and Pike, 2009, 2010). The BOLD signal isthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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which varies with vessel size and also with ﬁeld strength.
ΔBOLD
BOLD0
¼ M 1− CMRO2
CMRO2j0
 β CBF
CBF0
 α−β 
ð1Þ
In the Davis model the calibration parameter M is deﬁned as
TE × A × CBV0 × [dHb]v0β , where TE is the BOLD-weighted echo time, A
is a proportionality constant which depends on ﬁeld strength and tissue
properties, CBV0 is the baseline CBV and [dHb]v0 is the baseline venous
deoxyhemoglobin concentration of the blood (Hoge et al., 1999). There-
fore, the calibration parameter is expected to vary with inter-subject or
inter-session variations in physiology and tissue type. Hence it is neces-
sary to calculate M during each scan session. This is most commonly
achieved by applying an isometabolic stimulus, such as mild hypercap-
nia, during which CMRO2 is assumed to remain constant (Hoge, 2012).
Eq. (1) can then be rearranged to estimate M given measurements of
the changes in CBF and BOLD signal acquired during the hypercapnic
challenge.
The deﬁnition of M also describes a dependence on the BOLD
weighted TE. Sincemany different values of TE have been used through-
out the literature it is often instructive to be able to scale the calibration
parameter to the optimal BOLD echo time for each ﬁeld strength, which
in this studywere considered to be 50/35/25ms at 1.5/3/7 T, respective-
ly (van der Zwaag et al., 2009). To do this we assume that A has no de-
pendence on TE, andmultiply the experimental M by the ratio (optimal
TE/actual TE).
Methods
BOLD signal simulations
A detailedmodel of the BOLD signal (Griffeth and Buxton, 2011)was
used to simulate the hypercapnia calibration experiment, with the aim
of predicting general trends in M across ﬁeld strengths and to aid in
interpreting experimental results. The original detailed signal model
was designed to simulate the BOLD signal at 3 T. In order to extend
the model to 1.5 and 7 T a fewmodiﬁcations were made, which are de-
tailed below. In brief, the basic model consists of a volume-weighted
sum of arterial (a), capillary (c) and venous (v) intravascular compart-
ments and a single extravascular (e) compartment.
S ¼ 1−Va−Vc−Vvð ÞSe þ VaSa þ VcSc þ VvSv ð2Þ
The signal contributions were summed according to Eq. (2) under
baseline and hypercapnic conditions and combined to simulate the
BOLD signal change (see appendix of Griffeth and Buxton (2011)). Ex-
travascular signals (Se) were modelled using the results of numerical
simulations for two vessel scales to reﬂect the different signal character-
istics of capillaries (β= 2) compared with arteries and veins (β= 1)
(Ogawa et al., 1993). These signals were added to the baseline R2⁎ of
the extravascular tissue space (R2E*(0)). Intravascular signal contribu-
tions (Sa, Sc, Sv) have been described by empirical measurements of
the blood transverse relaxation rate R2⁎ as a function of oxygenation
and haematocrit (Zhao et al., 2007). Models of both extravascular and
intravascular signal enabled the effects of blood oxygenation and
haematocrit to be simulated. Blood was distributed to each of the com-
partments as a fraction (Ω) of the total CBV (VT), e.g. Va=Ωa VT. Relative
volume fractionswere set asΩa=0.2,Ωc=0.4, andΩv=0.4. However,
the model described thus far is only applicable at 3 T.
The following modiﬁcations were made to enable simulations to be
performed at all three ﬁeld strengths used in this study. The existing
empirical measurements of blood R2⁎ were replaced by the results of a
multi-ﬁeld relaxometry experiment (Blockley et al., 2008). Due to the
limited 7 T relaxometry literature it was only possible to generalise
R2* for oxygenation and not haematocrit. The quadratic relationship ofR2⁎ on oxygenation was retained, i.e. R2⁎ = C1 + C2 × (1− Y)2, where
C1 and C2 are ﬁeld strength speciﬁc constants and Y is the fractional
blood oxygenation. Therefore, unlike the previous model where R2*
was modelled as a function of oxygenation and haematocrit, the intra-
vascular signal dependence on oxygenation in the present study was
described for a ﬁxed haematocrit (Hct = 0.44) at all ﬁeld strengths.
Whilst this limits the ability of the model to test the effect of inter-
subject physiological variability, it enables general trends in M to be in-
vestigated across a range of ﬁeld strengths. Baseline extravascular tissue
R2⁎ values (R2E*(0)) were assigned ﬁeld-speciﬁc values based on
relaxometric measurements made at each ﬁeld strength (van der
Zwaag et al., 2009). BOLD echo times were set to match the experimen-
tal acquisition. These parameters are summarised in Table 1.
Simulations were initially performed for the baseline physiological
state of a hypothetical average healthy individual. Haematocrit was
set to be 0.44 (McPhee and Hammer, 2009), oxygen extraction fraction
(OEF) was set at 0.4 (Hatazawa et al., 1995) and total CBV for grey mat-
ter was set as 0.05 (Perlmutter et al., 1987). Hypercapnia calibration
was simulated as a 30% increase in CBF with no change in CMRO2. The
BOLD signal response to this challengewas simulated using the detailed
BOLD signal model. The BOLD and CBF changes were then combined
with Eq. (1) to calculate M at each ﬁeld strength using an α of 0.2
(Chen and Pike, 2009, 2010) and β values of 1.5/1.3/1.0 at 1.5/3/7 T re-
spectively, consistent with the literature (Bulte et al., 2009; Davis et al.,
1998; Driver et al., 2012). Estimates of M are dependent on the baseline
physiological state of the individual and it is therefore expected to vary
across the population. To test how this variability is affected by different
ﬁeld strengths,Mwas estimated for BOLD signals generatedwith sever-
al values for baseline CBV and OEF. Perlmutter et al. (1987) recorded a
mean CBV of 0.05 ± 0.01. Extending the range to 2 standard deviations
from the mean, limits of 0.03 and 0.07 were also simulated. Similarly,
resting OEF values of 0.3, 0.4 and 0.5 were investigated (Hatazawa
et al., 1995) whilst keeping CBV constant at 0.05. Simulated M values
were linearly scaled to the optimal TE values for each ﬁeld strength
for comparison purposes.
MRI parameters
Subjects were scanned on 1.5 T Avanto, 3 T Verio and 7 T systems
(Siemens Healthcare, Erlangen, Germany) with 12-channel (1.5 T) and
32-channel (3 and 7 T) head coils. Scans were carried out on separate
days to minimize the effects of fatigue and habituation. Because speciﬁc
absorption rate (SAR) was anticipated to be a limiting factor on se-
quence design at 7 T, a pulsed (rather than pseudo-continuous) ASL se-
quence was implemented to measure CBF (Alsop et al., 2015). Flow-
sensitive alternating inversion recovery (FAIR) (Kim, 1995) was chosen
tominimize the effects of B1 inhomogeneity (Gardener et al., 2009), and
the QUIPSS II scheme (Wong et al., 1998) was used to improve quanti-
ﬁcation of perfusion.
A single echo at 17ms provided sufﬁcient signal to noise ratio (SNR)
for both CBF and BOLD analysis at 3 and 7 T; a dual echo version of the
same sequence was implemented at 1.5 T with echoes at 17 and 50 ms
to ensure sufﬁcient BOLD contrast. All other imaging parameters were
kept constant across scanners. Six slices were acquired (limited by
SAR at 7 T) with an echo-planar imaging (EPI) readout and were placed
axially to cover themotor cortex. For consistency across scanners, no ac-
celeration methods (such as parallel imaging or partial Fourier) were
used. Bandwidth was set to 3004 Hz/Px, inversion times were TI1 =
700 and TI2= 1800ms, and repetition timewas 3 s. Note that in pulsed
ASL the bolus duration is ﬁxed by TI1 and the effective post-labelling
delay (PLD) is given by TI2–TI1 (Alsop et al., 2015), so 1100ms in this ex-
periment. It is common to use shorter PLDs in pulsed ASL compared to
(pseudo-)continuous implementations to compensate for the reduced
SNR inherent in pulsed ASL. Although this may result in incomplete de-
livery of tagged blood to the imaging slices, it is alsomore suited to gas-
calibrated experiments, where arterial arrival times are shortened
Table 1
Simulation parameters that change with ﬁeld strength.
Variable 1.5 T 3 T 7 T Description
C1 7.2 s−1 13.8 s−1 75.2 s−1 Constant term in quadratic dependence of intravascular R2* on oxygenation (Blockley et al., 2008)
C2 95.1 s−1 276.0 s−1 831.9 s−1 Quadratic term in quadratic dependence of intravascular R2* on oxygenation (Blockley et al., 2008)
R2E*(0) 11.6 s−1 18.1 s−1 30.8 s−1 Resting extravascular rate of signal decay (van der Zwaag et al., 2009)
TE 50 ms 17 ms 17 ms BOLD echo time
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slice gap in order that SNR of ASL data at 1.5 T did not become prohibi-
tively low. FAIR labelling used a 60 mm selective and a 260 mm non-
selective slab at all ﬁeld strengths.
Functional and respiratory tasks
A bilateral ﬁnger tapping motor task was chosen to easily allow a
consistent implementation across scanner suites. Subjects were given
audio cues over the intercom systems and were instructed to perform
4 blocks of self-paced ﬁnger tapping (48 s ON, 48 s OFF). This was
followed by 2 blocks of hypercapnia (3 min duration, each followed by
2 min of air), as shown in Fig. 1. Subjects were instructed to perform
the motor task at a fast but comfortable rate, and these instructions
were repeated prior to each scan session. Performance of the task was
monitored from the control room and all subjects were observed to
fully cooperate.
Gas delivery and sampling was achieved through a nasal cannula
(dual Nare, Flexicare, Mountain Ash, UK) in conjunction with a CO2
gas analyzer (CO2 100C Biopac Systems, Goleta, CA, USA). A 10% CO2/
21% O2 gas mixture with balance nitrogen was delivered, which mixed
with room air at a ratio of approximately 1:1, resulting in an ~5% CO2
stimulus. In order to minimize subject awareness of the hypercapnia
stimulus, medical air (21%O2with balance nitrogen)was delivered dur-
ing periods of air breathing, including during the motor tasks.
Analysis
Data were analyzed using the FMRIB Software Library (FSL) and the
fMRI Expert Analysis Tool (FEAT) (Woolrich et al., 2009). Preprocessing
consisted of motion correction (Jenkinson et al., 2002), brain extraction
(Smith, 2002) and ﬁeldmap correction (Jenkinson et al., 2012).
Highpass ﬁlters of 10 and 300 s were applied for ASL and BOLD respec-
tively, and no spatial smoothing was applied. The following contrasts
were input as part of a general linear model within FEAT: (1) tag-
control signal, modelled as a square on/off shape, which describes base-
line perfusion; (2) BOLD response to motor tasks A + B, with a haemo-
dynamic response function modelled as a gamma convolution with
mean lag 6 s, standard deviation 3 s; (3) BOLD response to motor
tasks C + D, as above; (4) BOLD response to hypercapnia, modelled
with a gamma convolution with mean lag 42 s, standard deviation
30 s to account for the delay between switching to the CO2 mixture
and the cerebrovascular response to increased arterial partial pressure
of CO2 in the brain; (5–7) blood ﬂow responses to motor tasks A + B,Fig. 1. Diagram showing timing of stimulC + D and hypercapnia, modelled as interactions between contrasts
(1) and the three BOLD responses, respectively. In this context, the
term “interaction” refers to the ﬁtting of the product of two existing
contrasts, andmay bemodelled in FEAT simply by checking the relevant
tick box. To avoid circular analysis (Kriegeskorte et al., 2009), data from
motor tasks A + B were used to create a region of interest (ROI), and
only data acquired duringmotor tasks C +Dwere analyzed to quantify
response tomotor stimuli (see Fig. 1). Other combinations of block-wise
analysis were investigated (e.g. A + D for ROI deﬁnition, B + C for data
analysis), and this choice was found to have no substantial impact on
the results.
Twomethodswere used to createmotor ROIs. First, a “BOLDonly”ROI
was deﬁned as the 40% of voxelswith the highest uncorrected voxel-wise
z-stats in response tomotor tasks (A+ B only, see Fig. 1). This cutoff was
used in place of setting a z-stat threshold directly as it was more consis-
tent between subjects and particularly across ﬁeld strengths. Similarly, a
grey matter (GM) mask was created from the 40% of voxels with the
most signiﬁcant baseline tag-control signal difference. Multiplication of
the BOLD ROI and GMmask produced a “BOLD/GM”motor ROI. The cre-
ation of “CBF only” and “BOLD/CBF overlap” ROIs was not possible due to
the low SNR of ASL data, particularly at 1.5 T.
Further analysis was performed on coefﬁcient of parameter estimate
(COPE) outputs of the FEAT analysis in MATLAB (MathWorks, Natick,
MA, USA). BOLD signal responses were normalized with respect to the
mean signal over the entire time course, and CBF responses were nor-
malized to the baseline perfusion signal, as output by the tag-control
COPE. Voxels with a BOLD response to either motor or hypercapnia
stimuli b0 or N0.10, or a CBF response b1 (no change) or N3 (+200%
relative to baseline), were assumed to be noise or to contain signiﬁcant
fractions ofwhitematter or cerebrospinalﬂuid, andwere excluded from
further analysis. Mean values within the remaining voxels for BOLD and
CBF responses to motor tasks (C+ D) and to hypercapnia were used to
calculate M and relative CMRO2 on a per subject basis, according to
Eq. (1), with the assumption that mild hypercapnia does not alter
CMRO2. The Grubb exponent α was set at 0.2 for all ﬁeld strengths
(Chen and Pike, 2009, 2010), and β values of 1.5/1.3/1.0 were used at
1.5/3/7 T respectively (Bulte et al., 2009; Davis et al., 1998; Driver
et al., 2012). Finally, M values at 3 and 7 T were scaled to optimal echo
times for comparison purposes.
Relative changes in CMRO2 induced by the motor tasks were com-
pared across ﬁeld strengths using the one sample paired t-test, where
the null hypothesis that measured CMRO2 changes are independent of
ﬁeld strength was rejected if p b 0.05. Bland–Altman diagrams were
used to investigate any systematic biases between ﬁeld strengths. ASLi. Total paradigm length 17 min 12 s.
192 H.V. Hare et al. / NeuroImage 112 (2015) 189–196image SNR was calculated from a single resting tag-control subtracted
time point, as the mean ASL signal within the BOLD/GM ROI divided
by the standard deviation in a non-brain ROI. In order to avoid unfair
bias, noisy voxels were not excluded from the BOLD/GM ROI for this
calculation.
Results
BOLD signal simulations
Simulations of hypercapnia calibration using a CBV of 0.05 and the
actual experimental TE's used predicted M values of 0.085 at 1.5 T,
0.076 at 3 T and 0.191 at 7 T. When scaled to the optimal TE values, M
was predicted to be 0.085 at 1.5 T, 0.156 at 3 T and 0.281 at 7 T. These
optimal values are plotted in Fig. 2 as crosses; circles and triangles rep-
resent the predictedMvalues for±2 standard deviations for physiolog-
ical CBV values respectively. The simulations predict that variation in
resting CBV leads to a greater range of M values at higher magnetic
ﬁeld strengths. Similar increases in the range of M values with ﬁeld
strengthwere observedwhen the range of baseline total OEFwas inves-
tigated (data not shown).
Experiment
Ten consenting subjects (3 females, mean age 29 ± 6 years) were
successfully scanned on 1.5, 3 and 7 T systems. Examples of fractional
BOLD and CBF responses tomotor tasks are shown in Fig. 3. Group aver-
age responses to hypercapnia and motor tasks are summarised in
Table 2. End-tidal CO2 levels were monitored throughout the course of
the experiments; however, the equipment performed poorly and the
resultant traces were deemed unreliable, and thus are not reported
here. Although unconﬁrmed, the authors have no reason to believe
that end-tidal CO2 modulations were inconsistent between the three
scan suites. The BOLD response appears smallest at 3 T because of the
shorter than usual echo time (TE = 17 ms), whereas the echo times
used at 1.5 and 7 T were close to the ﬁeld-optimized values. Neverthe-
less, the BOLD signal at this shorter echo time of 17 ms at 3 T was easily
sufﬁcient for this analysis; hence a second echo was not acquired.
Changes in CBF are consistent between 3 and 7 T but are substantially
higher at 1.5 T for both stimuli and both ROIs.
Fig. 4 shows how M and relative CMRO2 to motor tasks vary with
ﬁeld strength, where each blue cross represents an individual subject,
and group means are indicated by red circles. The BOLD/GM ROI pro-
duces consistently higher M estimates than the BOLD only ROI. There
is a much larger standard deviation in M values at 7 T than at 1.5 orFig. 2. Simulated M values produced using the detailed BOLD signal model. Triangles,
crosses and circles represent the predicted M values for individuals with a blood volume
fraction of 0.03, 0.05 and 0.07 respectively.3 T; however this variability does not propagate to CMRO2, where the
largest inter-subject standard deviation was always seen at 1.5 T.
One sample paired t-tests were carried out to determine whether
relative CMRO2 changes were consistent between ﬁeld strengths. For
theBOLD/GMROI analysis, 1.5 T and3 T resultswere shown to be incon-
sistent (p = 0.022). Similarly, the null hypothesis was rejected when
comparing 1.5 T and 7 T (p b 0.001). However, 3 T and 7 T did not
yield signiﬁcantly different results (p= 0.166).When considering rela-
tive CMRO2 in the BOLD only ROI, only 1.5 T vs. 7 T reached statistical
signiﬁcance (p = 0.001).
The Bland–Altman diagrams in Fig. 5 show graphically that the rela-
tive CMRO2 tomotor tasks as estimated by the Davis model at 3 and 7 T
are in good agreement. However, they are consistently higherwhen car-
ried out at 1.5 T, compared with either 3 or 7 T, by an average of ~10%
(using the BOLD/GM ROI).
CBF responses to motor tasks (Fig. 6) and hypercapnia (data not
shown) had a signiﬁcantly broader distribution at 1.5 T than at 3 or
7 T. After applying voxel exclusion criteria (illustrated by solid red
lines in Fig. 6), the mean of the remaining voxels (indicated by the
dashed lines) was larger at 1.5 T than at higher ﬁelds. For illustrative
purposes Fig. 6 includes data from all 10 subjects, but the same trends
were seen at the single subject level.
Finally, Fig. 7 shows how the SNR of resting ASL data increases with
ﬁeld strength. This is generally considered to be the limiting factor on
the accuracy of calibrated BOLD methods, as the ASL signal – the differ-
ence between tag and control images – is always substantially smaller
than the directly measured BOLD signal.
Discussion
Measurements of stimulus evoked changes in CMRO2 using gas cal-
ibrated fMRI provide a more direct physiological measurement of un-
derlying neural activity than standard BOLD fMRI. The technique was
developed at 1.5 T and has increased in popularity with the more wide-
spread availability of 3 T systems. However, very little research has been
published to date regarding the translation of the technique to 7 T. Sim-
ulations predict that the Davis model parameters must be adjusted for
this increase in ﬁeld strength by using a β value of 1, compared with
1.5 and 1.3 at ﬁeld strengths of 1.5 T and 3 T (Blockley et al., 2013;
Griffeth et al., 2013). The small number of published experimental 7 T
studies have universally used β= 1, consistent with these simulations
(Driver et al., 2012; Hall et al., 2012; Krieger et al., 2014). The potential
advantages of performing calibrated fMRI at 7 T come from improved
image SNR for both BOLD and ASL (Triantafyllou et al., 2005) and an in-
crease in longitudinal relaxation times for ASL resulting in higher SNR
CBF estimates (Franke et al., 2000). This increased SNR has so far been
used to produce maps of M (Hall et al., 2012) and to incorporate per-
subject measurements of changes in CBV, rather than assume a ﬁxed
CBF–CBV coupling (Driver et al., 2012). However, the accuracy of
CMRO2 measurements made at 7 T has until now been untested. In
this study the validity of the calibrated fMRI technique across ﬁeld
strengths was investigated by examining the consistency of measure-
ments acquired at 1.5 T, 3 T and 7 T.
Main ﬁndings
The relative changes in CBF and CMRO2 in response to a motor task
observed in this study are broadly in line with those reported in the lit-
erature. For example, Donahue et al. (2009) reported a CBF increase of
46 ± 11% and CMRO2 increase of 12 ± 13% at 3 T; Kastrup et al.
(2002) reported a CBF increase of 71 ± 9% and a CMRO2 increase of
16 ± 9% at 1.5 T; Petr et al. (2014) reported a group average CBF in-
crease of 47.2% at 3 T; Stefanovic et al. (2006) reported a CBF change
of 45.6 ± 0.57% at 1.5 T; and Vilela et al. (2011) reported a CBF change
of 62 ± 7% at 3 T. All of these studies also used pulsed ASL techniques.
Fig. 3. ASL and BOLD responses to motor tasks for one representative subject. ASL units are normalized to baseline, as are BOLD signal increases. Note that no smoothing has been applied.
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strength (Fig. 4), consistent with the results of the detailed BOLD signal
model simulations (Fig. 2). M values at 7 T were found to have the larg-
est standard deviation, despite the predicted improvements in SNR
(Table 2). Simulations indicate that variations in the underlying cerebral
physiology (such as CBV and OEF) will result in a broader range of M
values as magnetic ﬁeld increases. This suggests that the increase in
the standard deviation ofM at higher ﬁelds is due to differences in phys-
iology across the subject group, rather than an increase in randomnoise.
This ability of M to control for physiological variability is an important
characteristic of the Davis model, meaning that this variability is not
propagated through to estimates of CMRO2 change.
Intra-subject CMRO2 was consistent between 3 and 7 T, which is en-
couraging for research centres investing in ultra-high ﬁeld scanners. Fu-
ture studies at these high ﬁelds could make use of the improved SNR to
image at a higher resolution than has been possible until now. Changes
in CMRO2 measured at 1.5 T were consistently greater than those at 3
and 7 T (Figs. 4 and 5). We hypothesize that this is an artefact of the
lower SNR of 1.5 T scanners (see Fig. 7) combined with our voxel inclu-
sion criteria for ROI analysis, which together artiﬁcially increase theTable 2
Summary of results.
1.5 T 3 T 7 T
BOLD only
ROI
ΔBOLD to CO2 0.017 ± 0.005 0.010 ± 0.002 0.017 ± 0.006
ΔBOLD to
motor
0.012 ± 0.003 0.007 ± 0.002 0.014 ± 0.004
CBF to CO2 1.34 ± 0.05 1.24 ± 0.05 1.24 ± 0.07
CBF to motor 1.58 ± 0.08 1.41 ± 0.05 1.42 ± 0.07
M 0.055 ± 0.015 0.051 ± 0.011 0.115 ± 0.044
M at optimal TE 0.055 ± 0.015 0.105 ± 0.023 0.169 ± 0.064
CMRO2 to
motor
1.26 ± 0.08 1.19 ± 0.06 1.13 ± 0.07
Voxels
analyzed
118 ± 41 197 ± 61 204 ± 88
BOLD/GM ROI ΔBOLD to CO2 0.018 ± 0.005 0.009 ± 0.002 0.016 ± 0.006
ΔBOLD to
motor
0.013 ± 0.003 0.006 ± 0.001 0.014 ± 0.004
CBF to CO2 1.20 ± 0.05 1.13 ± 0.03 1.12 ± 0.03
CBF to motor 1.47 ± 0.08 1.31 ± 0.05 1.33 ± 0.05
M 0.088 ± 0.024 0.072 ± 0.012 0.186 ± 0.079
M at optimal TE 0.088 ± 0.024 0.149 ± 0.026 0.274 ± 0.116
CMRO2 to
motor
1.25 ± 0.07 1.17 ± 0.05 1.15 ± 0.04
Voxels
analyzed
61 ± 23 95 ± 35 94 ± 44
Summary of experimental results, given as mean ± standard deviation. CBF and CMRO2
have been normalized to baseline values (no change = 1), and ΔBOLD and M are given
as fractional changes with respect to baseline (no change = 0). Optimal echo time (TE)
is 50/35/25 ms at 1.5/3/7 T respectively.average CBF response of the remaining voxels for analysis at 1.5 T as
compared to 3 and 7 T. As Fig. 6 shows, the distribution of motor re-
sponses ismuch broader at 1.5 T than at higher ﬁeld strengths, elevating
the mean of remaining voxels.
The exclusion of approximately 50% of voxels from further analysis
within the BOLD/GM ROI at 1.5 T is a cause for concern. In experiments
carried out at either 3 or 7 T, ROIs are typically deﬁned from voxels that
exhibit positive BOLD and ASL responses (either in absolute terms or
those with the highest z-stats) to tasks, and there is no need to deﬁne
an additional “GM” criterion. Unfortunately due to the poor SNR of
pulsed ASL data, especially at 1.5 T, this was not viable in the current
study and it was necessary to rely only on BOLD and resting ASL data
for ROI determination. Fig. 6 highlights the difﬁculties when using
pulsed ASL at 1.5 T, demonstrating that the high level of noise can intro-
duce signiﬁcant biases during analysis, and that these results should be
interpreted with caution.ROI selection
The large physiological and inherent scanner noise present in func-
tional data, especially in ASL, presents a challenge. Increasing voxel
size helps to increase SNR, but at the cost of lower speciﬁcity and greater
partial volumingwithin voxels. This canmake it difﬁcult to create accu-
rate GMmasks, as many voxels will contain a mix of tissue types. In ad-
dition, the small number of slices and large voxels acquired in the
current study made accurate co-registration of functional to structural
data impossible. As a surrogate, good tag-control contrast in resting
ASL data (i.e. high baseline perfusion) was used to deﬁne GM voxels
(Gauthier and Hoge, 2013).
The choice of ROI – in this case, BOLD only versus BOLD/GM – had a
signiﬁcant impact on the ensuing estimates of M. Values calculated
within the BOLD only motor ROI were comparable with results from
previous studies at 3 T, at which the majority of calibrated fMRI studies
have been carried out (see Table 3). M values in the BOLD/GM ROI were
larger, but were in closer agreement with the predictions of the simula-
tions. This is likely a reﬂection on the assumptions of the detailed BOLD
signal model used for simulations. In contrast themethod used to create
the BOLD only ROI intentionally followed the analysis procedure from
past studies rather than matchingmodelling assumptions. Recent stud-
ies at 7 T have taken greater care to extract only GM voxels for analysis,
withmethods and resultingMvaluesmore similar to our BOLD/GMROI.
Studies at 3 T have also recommended deﬁning ROIs based on mapping
stimulus evoked changes in CBF, which have been shown to result in
greater reproducibility of CMRO2 estimates across sessions (Leontiev
and Buxton, 2007). Deﬁning the ROI in this manner is also likely to
more closely align with the assumptions of the detailed BOLD signal
Fig. 4.M and relative CMRO2 as a function of ﬁeld strength. Individual subjects are marked by blue crosses, group means by red circles.
194 H.V. Hare et al. / NeuroImage 112 (2015) 189–196model. However, our ability to apply this technique in this study was
limited by the SNR of the ASL measurements, particularly at 1.5 T.
Because of the wide distribution of CBF changes within both ROIs, it
was necessary to exclude some further voxels from later analysis.
Thresholds were applied to include only those voxels with relative
changes in CBF between 1 and 3 (in response to motor or hypercapnia
stimuli) in order to remove voxels that were deemed unacceptably
noisy or contained an insufﬁcient fraction of grey matter. However, as
the remaining voxels do not even approximate a normal distribution
(see Fig. 6), neither themean nor median values truly capture the over-
all ﬂow response in the ROI. Nonetheless we followed convention and
used mean values for further analysis, but this caused a noticeably
higher apparent blood ﬂow responses at 1.5 T as compared to 3 and
7 T (see Table 2).
The results of this study suggest that the Davis model is reassuringly
insensitive to ﬁeld strength, provided that the value for β is adjusted ap-
propriately (Bulte et al., 2009; Davis et al., 1998; Driver et al., 2012). The
observation that choice of ROI has a large effect onMbut only aminimal
impact on CMRO2 is a reﬂection of the power of themodel in regressing
out potentially confounding parameters. By combining all auxiliary pa-
rameters into one calibration constant, M, the model becomes veryFig. 5. Bland–Altman plots comparing relative CMRO2 to motor tasks (BOLD/GM ROI) at differe
tervals as dashed lines.wide-ranging and remains relatively insensitive to residual factors, at
least within healthy tissue.
Limitations
The primary question that this study sought to answer waswhether
the translation of calibrated fMRI from3 to 7 Twould alter the estimated
changes in CMRO2 during a functional task. In an attempt to remove
confounding factors from this comparison, scan parameters were kept
constant wherever possible. This included implementing the same
pulse sequence (FAIR) with the same readout (single echo EPI at
17 ms). Unfortunately the use of a single echo was not feasible at
1.5 T, where the optimal BOLD echo time is much longer (50 ms or
more), so it was necessary to modify the sequence and add a second
echo at this lower ﬁeld strength. As a result of these choices, readouts
were acquired at close to optimal BOLD echo times at 1.5 T (50 ms, op-
timal is 50ms) and 7 T (17ms, optimal is 25ms), whereas the 3 T BOLD
signal was extracted from the 17ms echo despite a longer optimal TE of
35 ms. This discrepancy led to a lower experimental BOLD response at
3 T (see Table 2), and may have negatively impacted the BOLD SNR at
this ﬁeld strength. The lower BOLD value was accounted for by thent ﬁelds. In all diagrams, mean differences are shown as solid lines and 95% conﬁdence in-
Fig. 6. Histograms of voxel-wise blood ﬂow response to motor tasks (C + D only), pooled from all 10 subjects' BOLD/GM ROIs. Solid red lines indicate cutoff conditions beyond which
voxels were excluded from further analysis; dashed red lines indicate means of remaining voxels.
Table 3
Comparison of M values in the current study with those in the literature.
Field Study ROI M (at optimal TE)
1.5 T Current study
(BOLD only ROI)
Motor 0.055 ± 0.015
Davis et al. (1998) Visual 0.056 ± 0.017
Stefanovic et al. (2006) Motor 0.061 ± 0.011
Stefanovic et al. (2004) Motor 0.072 ± 0.010
Current study
(BOLD/GM ROI)
Motor 0.088 ± 0.024
Kastrup et al. (2002) Motor 0.113 ± 0.038
195H.V. Hare et al. / NeuroImage 112 (2015) 189–196linear scaling of M value to the optimal echo time (see Methods sec-
tion), although of course this cannot recover the lost SNR.
SNR is inherently lower at 1.5 T compared with higher ﬁeld
strengths. This problem has been ampliﬁed in this study by the use of
a pulsed ASL sequence and a 12-channel head coil. In comparison to
(pseudo-)continuous ASL, pulsed ASL is more sensitive to changes in
ﬂow velocity during motor tasks and gas challenges, as shortened arte-
rial arrival times during stimulation may lead to differing volumes of
tagged blood arriving at the imaging planes. Furthermore, the increased
intravascular contribution to the BOLD signal at lower ﬁeld strengths
may further contribute to the CMRO2 discrepancy; in the absence of
large vessels, ~57% of all signal at 1.5 T is of intravascular origin, as com-
pared to ~36% at 3 T and a negligible contribution at 7 T (Uludag et al.,
2009). However, it has been shown that the Davis model can account
for this signal contribution via the parameters α and β (Griffeth and
Buxton, 2011).
Another consequence of the use of a pulsed ASL sequence is the
potential for underestimating ﬂow responses during hypercapnia.
Tancredi et al. (2012) have reported that although pulsed and pseudo-
continuous methods show good agreement in baseline perfusion and
focal activation responses, the global nature of the CBF increase during
hypercapnia appears to lead to an underestimation in ﬂow response
when pulsed ASL is used. This may have led to an overestimation in M
values and thus in relative CMRO2 estimates during motor tasks. How-
ever, this issue would have impacted all ﬁelds equally, and thus is not
expected to affect the conclusions of this study.
In order to implement the same protocol on all three scanners, it was
necessary to make several compromises in terms of sequence designFig. 7. Signal to noise ratios of subtracted ASL images (tag-control) at different ﬁeld
strengths during the baseline condition. Signal was measured in motor regions, deﬁned
by BOLD/GM ROIs (prior to the removal of noisy voxels). Error bars show± one standard
deviation.and choice of parameters. It is important to bear in mind that SNR at
1.5 and 3 T could be improved by implementing a pseudo-continuous
ASL sequence; similarly the intrinsically greater SNR at 7 T could be uti-
lized by increasing the resolution, which would also reduce physiologi-
cal noise (Triantafyllou et al., 2005). However, the primary aim of this
work was to fairly compare the outcomes of the Davis model as a func-
tion of ﬁeld strength only, by keeping as many other variables constant
as possible.
Conclusion
Changes in CMRO2 during a motor task, as calculated by the Davis
model, were consistent between 3 and 7 T andwere also in close agree-
ment with the results of theoretical simulations. This is encouraging for
future studies of calibrated fMRI at ultra-high ﬁelds, and supports theHoge et al. (1999) Visual (single)
Visual (graded)
0.15 ± 0.06
0.22 ± 0.03
3 T Chiarelli et al. (2007a) Motor 0.047 ± 0.038
Chen and Parrish (2009) Motor 0.056 ± 0.015
Ances et al. (2008) Visual 0.067 ± 0.002
Chiarelli et al. (2007b) Motor 0.069 ± 0.006 (oxygen)
Mark et al. (2011) Motor 0.081 ± 0.011
Ances et al. (2009) Visual 0.085 ± 0.006
Current study
(BOLD only ROI)
Motor 0.105 ± 0.023
Gauthier et al. (2011) Visual 0.111 (carbogen)
Lin et al. (2008) Visual 0.123 ± 0.003
Leontiev and Buxton (2007) Visual 0.130 ± 0.069
Perthen et al. (2008) Visual 0.141 ± 0.013
Current study
(BOLD/GM ROI)
Motor 0.149 ± 0.026
7 T Current study
(BOLD only ROI)
Motor 0.169 ± 0.064
Current study
(BOLD/GM ROI)
Motor 0.274 ± 0.116
Driver et al. (2012) Motor 0.28 ± 0.02 (oxygen)
Hall et al. (2012) Motor 0.29 ± 0.04
Krieger et al. (2014) Motor 0.309 ± 0.031 (carbogen)
All studies used hypercapnia unless indicated otherwise. Note that all M values and errors
have been linearly scaled to the optimal echo times of 50/35/25 ms for 1.5/3/7 T
respectively.
196 H.V. Hare et al. / NeuroImage 112 (2015) 189–196continued use of this simple signal model. The lower SNR at 1.5 T may
present problems for the calibrated fMRI method, which relies heavily
on ASL data. In this study the CMRO2 results were consistently over-
estimated at 1.5 T, although this may be a result of the sub-optimal
pulsed ASL sequence used. Voxel exclusion criteria and methods for
ROI creation for post-processing are important and should be carefully
considered and clearly stated in future studies, as they can have a signif-
icant impact on results.
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